These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37480099)

  • 41. Concomitant Use of Biopsy Clips and Wire Localization in Invasive Breast Cancer is Associated With Successful Clip Retrieval.
    Chen JH; Canner JK; Myers K; Camp M
    Clin Breast Cancer; 2023 Apr; 23(3):e163-e172. PubMed ID: 36646538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accuracy and Limitations of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes.
    Aragon-Sanchez S; Oliver-Perez MR; Madariaga A; Tabuenca MJ; Martinez M; Galindo A; Arroyo ML; Gallego M; Blanco M; Ciruelos-Gil EM
    Breast J; 2022; 2022():1507881. PubMed ID: 36051467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Axillary ultrasound after neoadjuvant therapy reduces the false-negative rate of sentinel lymph node biopsy in patients with cytologically node-positive breast cancer.
    Liu Y; Wang Y; Feng S; Xu Z; Yao M; Huang X; Li P; Wu L; Liu C; Chen X; Liang C; Liu Z
    Breast Cancer Res Treat; 2023 Feb; 197(3):515-523. PubMed ID: 36513955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients.
    Kuemmel S; Heil J; Rueland A; Seiberling C; Harrach H; Schindowski D; Lubitz J; Hellerhoff K; Ankel C; Graßhoff ST; Deuschle P; Hanf V; Belke K; Dall P; Dorn J; Kaltenecker G; Kuehn T; Beckmann U; Potenberg J; Blohmer JU; Kostara A; Breit E; Holtschmidt J; Traut E; Reinisch M
    Ann Surg; 2022 Nov; 276(5):e553-e562. PubMed ID: 33156057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective Evaluation of Radar-Localized Reflector-Directed Targeted Axillary Dissection in Node-Positive Breast Cancer Patients after Neoadjuvant Systemic Therapy.
    Gallagher KK; Iles K; Kuzmiak C; Louie R; McGuire KP; Ollila DW
    J Am Coll Surg; 2022 Apr; 234(4):538-545. PubMed ID: 35290273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Excision of both pretreatment marked positive nodes and sentinel nodes improves axillary staging after neoadjuvant systemic therapy in breast cancer.
    Simons JM; van Pelt MLMA; Marinelli AWKS; Straver ME; Zeillemaker AM; Pereira Arias-Bouda LM; van Nijnatten TJA; Koppert LB; Hunt KK; Smidt ML; Luiten EJT; van der Pol CC
    Br J Surg; 2019 Nov; 106(12):1632-1639. PubMed ID: 31593294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radio-isotope occult lesion localization (ROLL) techniques to identify the clipped node for targeted axillary dissection (TAD) in breast cancer.
    Winder AA; Spillane AJ; Sood S; McKessar M; Cohn D; Snook K
    ANZ J Surg; 2022 Nov; 92(11):3017-3021. PubMed ID: 36262092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgical Management of the Axilla in Breast Cancer Patients with Negative Sentinel Lymph Node: A Method to Reduce False-Negative Rate.
    Yuan Q; Wu G; Xiao SY; He Y; Wang K; Zhang D
    World J Surg; 2019 Apr; 43(4):1047-1053. PubMed ID: 30478688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Targeted axillary dissection using carbon marking for patients with node-positive breast cancer following neoadjuvant therapy (TADCOM): study protocol for a prospective, multicenter, randomized controlled trial.
    Chen W; Pang L; Jin X; Chen H; Huang J
    BMC Cancer; 2024 Oct; 24(1):1276. PubMed ID: 39402559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeted axillary dissection and sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy - a retrospective study.
    Coufal O; Zapletal O; Gabrielová L; Fabian P; Schneiderová M
    Rozhl Chir; 2018; 97(12):551-557. PubMed ID: 30646734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic accuracy of de-escalated surgical procedure in axilla for node-positive breast cancer patients treated with neoadjuvant systemic therapy: A systematic review and meta-analysis.
    Song YX; Xu Z; Liang MX; Liu Z; Hou JC; Chen X; Xu D; Fei YJ; Tang JH
    Cancer Med; 2022 Nov; 11(22):4085-4103. PubMed ID: 35502768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short-term and long-term outcomes of indocyanine green for sentinel lymph node biopsy in early-stage breast cancer.
    Hua B; Li Y; Yang X; Ren X; Lu X
    World J Surg Oncol; 2022 Aug; 20(1):253. PubMed ID: 35941602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer.
    Simons JM; van Nijnatten TJA; van der Pol CC; van Diest PJ; Jager A; van Klaveren D; Kam BLR; Lobbes MBI; de Boer M; Verhoef C; Sars PRA; Heijmans HJ; van Haaren ERM; Vles WJ; Contant CME; Menke-Pluijmers MBE; Smit LHM; Kelder W; Boskamp M; Koppert LB; Luiten EJT; Smidt ML
    JAMA Surg; 2022 Nov; 157(11):991-999. PubMed ID: 36069889
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ultrasound guided tattooing of axillary lymph nodes in breast cancer patients prior to neoadjuvant therapy, and identification of tattooed nodes at the time of surgery.
    Allweis TM; Menes T; Rotbart N; Rapson Y; Cernik H; Bokov I; Diment J; Magen A; Golan O; Levi-Bendet N; Givon Madhala O; Grubstein A
    Eur J Surg Oncol; 2020 Jun; 46(6):1041-1045. PubMed ID: 31801656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy.
    Balasubramanian R; Morgan C; Shaari E; Kovacs T; Pinder SE; Hamed H; Sever AR; Kothari A
    Eur J Surg Oncol; 2020 Jun; 46(6):1028-1033. PubMed ID: 31879050
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Axillary Lymph Node Tattooing and Targeted Axillary Dissection in Breast Cancer Patients Who Presented as cN+ Before Neoadjuvant Chemotherapy and Became cN0 After Treatment.
    Natsiopoulos I; Intzes S; Liappis T; Zarampoukas K; Zarampoukas T; Zacharopoulou V; Papazisis K
    Clin Breast Cancer; 2019 Jun; 19(3):208-215. PubMed ID: 30922804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intermediary clip placement to assist accurate axillary lymph node localization.
    Price ER; Vyas S; Lee AY; Wong JM; Joe BN; Ray KM
    Clin Imaging; 2021 May; 73():96-100. PubMed ID: 33352497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: Skin Mark clipped Axillary nodes Removal Technique (SMART trial).
    Lim GH; Teo SY; Gudi M; Ng RP; Pang J; Tan YS; Lee YS; Allen JC; Leong LCH
    Cancer Med; 2020 Mar; 9(6):1978-1985. PubMed ID: 31970894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer.
    Kuemmel S; Heil J; Bruzas S; Breit E; Schindowski D; Harrach H; Chiari O; Hellerhoff K; Bensmann E; Hanf V; Graßhoff ST; Deuschle P; Belke K; Polata S; Paepke S; Warm M; Meiler J; Schindlbeck C; Ruhwedel W; Beckmann U; Groh U; Dall P; Blohmer JU; Traut A; Reinisch M
    JAMA Surg; 2023 Aug; 158(8):807-815. PubMed ID: 37285140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neoadjuvant therapy and sentinel lymph node biopsy in HER2-positive breast cancer patients: results from the PEONY trial.
    Sun X; Wang XE; Zhang ZP; Shi ZQ; Cong BB; Wang YS; Shao ZM
    Breast Cancer Res Treat; 2020 Apr; 180(2):423-428. PubMed ID: 32034581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.